|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 25/28 | |
| A61K 31/445 | |||
| A61K 31/55 |
| (11) | Patento numeris | 1827468 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05771273.9 |
| Europos patento paraiškos padavimo data | 2005-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-09-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-08-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/024656 |
| Data | 2005-07-13 |
| (87) | Numeris | WO 2006/071274 |
| Data | 2006-07-06 |
| (30) | Numeris | Data | Šalis |
| 638123 P | 2004-12-23 | US |
| (72) |
GREGORY, Christopher, W., US
SMITH, Patrick, S., US
|
| (73) |
Curaxis Pharmaceutical Corporation,
1004 Chagford Way, Raleigh, NC 27614,
US
|
| (54) | Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer`s disease |
| Acetylcholinesterase Inhibitors and leuprolide acetate for the treatment of Alzheimer`s disease |